Physician profile
Waheed S Baksh
NPI 1033393871
$7,046.82
in general payments reported to CMS, 2019-2025
26 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $945 · 2021: $812 · 2022: $2,791 · 2023: $783 · 2024: $515 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,301.78 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $1,144.96 | 2019-2022 | |
| Flowonix Medical Incorporated | $696.05 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $273.88 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $248.43 | 2019-2025 | Xtampza, Belbuca |
| Curonix LLC | $216.60 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $154.26 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $145.81 | 2023-2024 | Sprint Pns System |
| Vertos Medical, INC. | $97.26 | 2024 | Mild Device Kit |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Medtronic USA, INC. | $89.68 | 2019 | |
| Fidia Pharma USA INC. | $87.04 | 2019-2025 | Hymovis, Triluron |
| Neuronetics, INC. | $78.13 | 2021 | |
| Mallinckrodt Hospital Products INC. | $62.53 | 2021 | |
| Biotronik Nro, INC. | $51.98 | 2024 | Prospera |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $45.24 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $37.78 | 2022-2023 | Seglentis |
| Daiichi Sankyo INC. | $32.02 | 2019 | |
| Stryker Corporation | $31.97 | 2024 | Mild Device Kit |
| Hikma Pharmaceuticals USA | $28.24 | 2021-2022 | |
| Painteq LLC | $25.10 | 2024 | Painteq |
| Nalu Medical, INC. | $23.72 | 2023 | Nalu Neurostimulation System |
| Nevro Corp. | $22.56 | 2020 | |
| Si-Bone, INC. | $21.97 | 2025 | |
| Pfizer INC. | $18.73 | 2019 | |
| Redhill Biopharma INC. | $18.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waheed Baksh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.